| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cure Pharmaceutical Holding Corp. | Director | Common Stock | 21,579 | $5,718 | $0.265 | 06 Aug 2020 | Direct |
| Cure Pharmaceutical Holding Corp. | Director | Restricted Stock Unit | 61,654 | 23 Sep 2020 | Direct | ||
| Aditxt, Inc. | Director | Restricted Stock Units | 14,000 | 29 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NVAC | NorthView Acquisition Corp | 20 Dec 2021 | 0 | $0 | 3 | Director | 20 Dec 2021, 20:37 |
| ADTX | Aditxt, Inc. | 14 Jul 2021 | 2 | $0 | 4 | Director | 01 Oct 2021, 21:45 |
| ADTX | Aditx Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | Director | 23 Jun 2021, 17:11 |
| AVRW | Cure Pharmaceutical Holding Corp. | 06 Aug 2020 | 2 | $0 | 4 | Director | 27 May 2021, 19:38 |
| AVRW | Cure Pharmaceutical Holding Corp. | 06 Aug 2019 | 0 | $0 | 3 | Director | 27 May 2021, 19:26 |